NAROVAC Progresses Toward Market Authorization

NAROVAC is advancing through the regulatory pathway toward market authorization. The NARO Vaccines and Pharmaceuticals Centre continues to prepare the required technical documentation and supporting evidence for submission to the responsible authorities.

Final availability and access-point information will be published through official channels when authorization and operational arrangements are confirmed.